MediciNova Receives Notice of Allowance for New Patent Covering the Combination of MN-166 Pharmaceutical Investing
Presentation of Clearside Biomedical’s Extension Study of PEACHTREE for XIPERE Pharmaceutical Investing
Life Science Big News Roundup: Biocure Signs a Collaboration Agreement with Y Biologics; PreveCeutical Provides Update on the Dual Gene Therapy Program; Lexaria Partners with Altria to Fund Research and Development of DehydraTECH(tm) Technology Life Science Investing
Kura Oncology Reports Clinical Activity of Tipifarnib in Subsets of Pancreatic Cancer Associated with High CXCL12 Expression Biotech Investing
TYME’s Novel Metabolic-Based Cancer Therapy, SM-88, Improves Survival in Phase II Study Biotech Investing
Immunomedics Receives Complete Response Letter From FDA for Sacituzumab Govitecan Biologics License Application Pharmaceutical Investing
